BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35942174)

  • 21. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma.
    Yin J; Zeng A; Zhang Z; Shi Z; Yan W; You Y
    EBioMedicine; 2019 Apr; 42():238-251. PubMed ID: 30917935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis.
    Cao W; He Y; Lan J; Luo S; Sun B; Xiao C; Yu W; Zeng Z; Lei S
    Cell Death Dis; 2024 Apr; 15(4):239. PubMed ID: 38561331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells.
    Erdem İS
    Anticancer Agents Med Chem; 2023; 23(19):2154-2160. PubMed ID: 37622695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion.
    Wan Y; Sun G; Zhang S; Wang Z; Shi L
    In Vitro Cell Dev Biol Anim; 2013 Sep; 49(8):599-607. PubMed ID: 23835866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1.
    Jia B; Liu W; Gu J; Wang J; Lv W; Zhang W; Hao Q; Pang Z; Mu N; Zhang W; Guo Q
    Exp Cell Res; 2019 Feb; 375(1):73-81. PubMed ID: 30586549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma Via Targeting MGMT.
    Wu H; Li X; Zhang T; Zhang G; Chen J; Chen L; He M; Hao B; Wang C
    Neuromolecular Med; 2020 Sep; 22(3):359-369. PubMed ID: 32086739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma.
    Zhang K; Wu L; Zhang P; Luo M; Du J; Gao T; O'Connell D; Wang G; Wang H; Yang Y
    Mol Carcinog; 2018 Nov; 57(11):1566-1576. PubMed ID: 30035324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.
    Haemmig S; Baumgartner U; Glück A; Zbinden S; Tschan MP; Kappeler A; Mariani L; Vajtai I; Vassella E
    Cell Death Dis; 2014 Jun; 5(6):e1279. PubMed ID: 24901050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
    Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
    J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma.
    Shang C; Tang W; Pan C; Hu X; Hong Y
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):671-678. PubMed ID: 29397407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide.
    Zhang S; Wan Y; Pan T; Gu X; Qian C; Sun G; Sun L; Xiang Y; Wang Z; Shi L
    J Mol Neurosci; 2012 Jun; 47(2):346-56. PubMed ID: 22528454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial progenitor cells-derived exosomes transfer microRNA-30e-5p to regulate Erastin-induced ferroptosis in human umbilical vein endothelial cells via the specificity protein 1/adenosine monophosphate-activated protein kinase axis.
    Xia J; Song X; Meng J; Lou D
    Bioengineered; 2022 Feb; 13(2):3566-3580. PubMed ID: 35068337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling.
    Lu Y; Tian M; Liu J; Wang K
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22848. PubMed ID: 34328678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2.
    Lee WJ; Shin CH; Ji H; Jeong SD; Park MS; Won HH; Pandey PR; Tsitsipatis D; Gorospe M; Kim HH
    Cell Death Dis; 2021 Mar; 12(4):290. PubMed ID: 33731671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
    Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z
    Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.